NeuRizer Ltd. Logo

NeuRizer Ltd.

NRZ.AX

(1.5)
Stock Price

0,00 AUD

-5.4% ROA

-10.02% ROE

-0x PER

Market Cap.

8.724.480,00 AUD

0.47% DER

0% Yield

0% NPM

NeuRizer Ltd. Stock Analysis

NeuRizer Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

NeuRizer Ltd. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.38x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (1%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

4 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

5 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

6 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

7 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

8 ROE

Negative ROE (-37.85%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

9 ROA

The stock's ROA (-22.27%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

10 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

11 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

NeuRizer Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

NeuRizer Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

NeuRizer Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

NeuRizer Ltd. Revenue
Year Revenue Growth
2005 0
2006 2.644 100%
2007 281 -840.93%
2008 2.945 90.46%
2009 5.291 44.34%
2010 655 -707.79%
2011 0 0%
2012 0 0%
2013 0 0%
2014 350 100%
2015 2.319 84.91%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

NeuRizer Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

NeuRizer Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 326.867
2006 828.072 60.53%
2007 2.408.858 65.62%
2008 3.580.106 32.72%
2009 1.693.152 -111.45%
2010 2.292.315 26.14%
2011 1.625.852 -40.99%
2012 1.667.793 2.51%
2013 1.209.367 -37.91%
2014 627.360 -92.77%
2015 563.456 -11.34%
2016 3.385.743 83.36%
2017 4.020.243 15.78%
2018 4.178.654 3.79%
2019 5.401.504 22.64%
2020 5.309.482 -1.73%
2021 7.020.371 24.37%
2022 8.921.249 21.31%
2023 10.535.929 15.33%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

NeuRizer Ltd. EBITDA
Year EBITDA Growth
2005 -497.200
2006 -1.496.128 66.77%
2007 -4.214.634 64.5%
2008 -5.173.578 18.54%
2009 -5.433.148 4.78%
2010 -4.283.878 -26.83%
2011 -3.111.689 -37.67%
2012 -19.274.742 83.86%
2013 -1.962.989 -881.91%
2014 -1.304.851 -50.44%
2015 -17.592.515 92.58%
2016 -5.325.559 -230.34%
2017 -5.645.404 5.67%
2018 -5.668.183 0.4%
2019 -7.312.706 22.49%
2020 -6.926.548 -5.58%
2021 -8.683.893 20.24%
2022 -12.293.944 29.36%
2023 -13.537.670 9.19%
2024 -1.192 -1135610.57%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

NeuRizer Ltd. Gross Profit
Year Gross Profit Growth
2005 0
2006 2.644 100%
2007 281 -840.93%
2008 2.945 90.46%
2009 5.291 44.34%
2010 655 -707.79%
2011 0 0%
2012 0 0%
2013 0 0%
2014 350 100%
2015 2.319 84.91%
2016 -35.664 106.5%
2017 -35.251 -1.17%
2018 -39.951 11.76%
2019 -59.116 32.42%
2020 -77.677 23.9%
2021 -179.732 56.78%
2022 -158.525 -13.38%
2023 -45.386 -249.28%
2024 -28.492 -59.29%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

NeuRizer Ltd. Net Profit
Year Net Profit Growth
2005 -417.044
2006 -1.454.267 71.32%
2007 -5.862.541 75.19%
2008 -5.351.634 -9.55%
2009 -5.605.221 4.52%
2010 -4.085.557 -37.2%
2011 -2.768.492 -47.57%
2012 -15.165.550 81.74%
2013 -2.055.085 -637.95%
2014 -1.562.678 -31.51%
2015 -17.598.147 91.12%
2016 -5.366.248 -227.94%
2017 -5.758.760 6.82%
2018 -6.018.850 4.32%
2019 -9.534.857 36.88%
2020 -7.154.941 -33.26%
2021 -13.574.173 47.29%
2022 -20.398.157 33.45%
2023 -16.262.136 -25.43%
2024 -1.598 -1017555.57%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

NeuRizer Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

NeuRizer Ltd. Free Cashflow
Year Free Cashflow Growth
2005 -270.725
2006 -2.159.555 87.46%
2007 -6.219.166 65.28%
2008 -8.534.280 27.13%
2009 -2.560.437 -233.31%
2010 -1.026.660 -149.39%
2011 -1.052.239 2.43%
2012 -210.960 -398.79%
2013 -2.792 -7455.87%
2014 6 46633.33%
2015 -1.615.758 100%
2016 -5.812.976 72.2%
2017 -8.797.536 33.92%
2018 -18.640.392 52.8%
2019 -16.938.693 -10.05%
2020 -1.855.088 -813.09%
2021 -8.270.598 77.57%
2022 -16.472.762 49.79%
2023 -34.319.011 52%
2024 -1.805 -1901230.25%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

NeuRizer Ltd. Operating Cashflow
Year Operating Cashflow Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 6 100%
2015 -905.091 100%
2016 -4.003.529 77.39%
2017 -3.059.459 -30.86%
2018 -3.134.788 2.4%
2019 3.332.287 194.07%
2020 904.920 -268.24%
2021 -4.613.694 119.61%
2022 -10.229.924 54.9%
2023 -9.048.230 -13.06%
2024 -980 -923188.78%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

NeuRizer Ltd. Capital Expenditure
Year Capital Expenditure Growth
2005 270.725
2006 2.159.555 87.46%
2007 6.219.166 65.28%
2008 8.534.280 27.13%
2009 2.560.437 -233.31%
2010 1.026.660 -149.39%
2011 1.052.239 2.43%
2012 210.960 -398.79%
2013 2.792 -7455.87%
2014 0 0%
2015 710.667 100%
2016 1.809.447 60.72%
2017 5.738.077 68.47%
2018 15.505.604 62.99%
2019 20.270.980 23.51%
2020 2.760.008 -634.45%
2021 3.656.904 24.53%
2022 6.242.838 41.42%
2023 25.270.781 75.3%
2024 825 -3066742.35%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

NeuRizer Ltd. Equity
Year Equity Growth
2005 4.185.111
2006 6.320.145 33.78%
2007 9.717.645 34.96%
2008 20.750.712 53.17%
2009 19.781.735 -4.9%
2010 17.019.535 -16.23%
2011 22.000.757 22.64%
2012 6.982.951 -215.06%
2013 5.087.928 -37.25%
2014 3.702.159 -37.43%
2015 1.889.651 -95.92%
2016 10.787.054 82.48%
2017 13.827.468 21.99%
2018 25.382.215 45.52%
2019 29.745.740 14.67%
2020 34.157.103 12.91%
2021 51.302.735 33.42%
2022 56.487.642 9.18%
2023 72.753.810 22.36%
2024 75.036.295 3.04%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

NeuRizer Ltd. Assets
Year Assets Growth
2005 4.363.669
2006 6.643.223 34.31%
2007 12.322.413 46.09%
2008 22.607.227 45.49%
2009 20.937.402 -7.98%
2010 17.996.681 -16.34%
2011 23.254.460 22.61%
2012 7.293.855 -218.82%
2013 5.217.282 -39.8%
2014 3.761.558 -38.7%
2015 2.394.162 -57.11%
2016 11.577.284 79.32%
2017 17.322.984 33.17%
2018 35.508.062 51.21%
2019 35.020.076 -1.39%
2020 35.932.450 2.54%
2021 55.182.821 34.88%
2022 91.606.250 39.76%
2023 128.667.290 28.8%
2024 127.839.000 -0.65%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

NeuRizer Ltd. Liabilities
Year Liabilities Growth
2005 178.558
2006 323.078 44.73%
2007 2.604.768 87.6%
2008 1.856.515 -40.3%
2009 1.155.667 -60.64%
2010 977.146 -18.27%
2011 1.253.703 22.06%
2012 310.904 -303.24%
2013 129.354 -140.35%
2014 59.399 -117.77%
2015 504.511 88.23%
2016 790.230 36.16%
2017 3.495.516 77.39%
2018 10.125.847 65.48%
2019 5.274.336 -91.98%
2020 1.775.347 -197.09%
2021 3.880.086 54.24%
2022 35.118.608 88.95%
2023 55.913.480 37.19%
2024 52.802.753 -5.89%

NeuRizer Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-5.37
Price to Earning Ratio
-0x
Price To Sales Ratio
0x
POCF Ratio
-0
PFCF Ratio
-0.98
Price to Book Ratio
0
EV to Sales
0
EV Over EBITDA
-2779.03
EV to Operating CashFlow
-1.89
EV to FreeCashFlow
-0.92
Earnings Yield
-1342.67
FreeCashFlow Yield
-1.02
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
84.01
Graham NetNet
-40.44

Income Statement Metrics

Net Income per Share
-5.37
Income Quality
0.63
ROE
-0.1
Return On Assets
-0.05
Return On Capital Employed
-0.06
Net Income per EBT
1
EBT Per Ebit
1.45
Ebit per Revenue
0
Effective Tax Rate
-0.69

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-3.38
Free CashFlow per Share
-6.93
Capex to Operating CashFlow
-1.05
Capex to Revenue
0
Capex to Depreciation
831645
Return on Invested Capital
-0.11
Return on Tangible Assets
-0.05
Days Sales Outstanding
0
Days Payables Outstanding
2569959.31
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
31378854625551
Capex per Share
3.55

Balance Sheet

Cash per Share
0,66
Book Value per Share
58,40
Tangible Book Value per Share
58.4
Shareholders Equity per Share
58.4
Interest Debt per Share
2.71
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
166.59
Current Ratio
0.03
Tangible Asset Value
0,08 Bil.
Net Current Asset Value
-0,05 Bil.
Invested Capital
75218303
Working Capital
-0,05 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,05 Bil.
Average Inventory
0
Debt to Market Cap
0.04

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

NeuRizer Ltd. Dividends
Year Dividends Growth

NeuRizer Ltd. Profile

About NeuRizer Ltd.

NeuRizer Ltd. focuses on producing carbon neutral fertilisers in Australia. It has NeuRizer Urea project that deliver nitrogen-based fertilizers for agricultural markets in south Australia. NeuRizer Ltd. was formerly known as Leigh Creek Energy Limited and changed its name to NeuRizer Ltd. in March 2022. The company was incorporated in 2004 and is based in Adelaide, Australia.

CEO
Mr. Daniel Justyn Douglas Pete
Employee
0
Address
19 Grenfell Street
Adelaide, 5000

NeuRizer Ltd. Executives & BODs

NeuRizer Ltd. Executives & BODs
# Name Age
1 Ms. Jordan Eliza Mehrtens B.Com., L.L.B.
Company Secretary & Non-Executive Director
70
2 Mr. Daniel Justyn Douglas Peters B.A., L.L.B., LLB
Executive Chairman
70
3 Mr. Cristian Bolda
Chief Operating Officer
70

NeuRizer Ltd. Competitors